m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs
Fibrotic Diseases N6-methyladenosine (m6A) methylation is a dynamic and reversible process that affects mRNA modifications, influencing multiple steps in mRNA processing. This review highlights recent advances regarding the impact of m6A methylation on visceral organ fibrosis and discusses potential therapeutic prospects for treating fibrotic diseases. More in article number 2400308, Wei Zhang, Jie Chao, and co-workers.
Authors
- Cuifen Wang
- Wei Luo (ORCID: https://orcid.org/0000-0001-6951-7698)
- Jie Chao (ORCID: https://orcid.org/0000-0002-7800-3557)
- Xinxin Zhang (ORCID: https://orcid.org/0000-0002-6229-0029)
- Jing Wang (ORCID: https://orcid.org/0000-0003-2410-5408)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-4375-0368)
- Yusi Cheng (ORCID: https://orcid.org/0000-0003-0988-6269)
- Xiaoniu Dai
Institutions
- Zhongda Hospital Southeast University (CN)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Small Science
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1002/smsc.202570009
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00